The Journal of Organic Chemistry
Note
temperature, aqueous NH4Cl (saturated, 2.0 mL) was added. The
aqueous layer was extracted five times with Et2O. The combined
organic extracts were filtered with a pad of Florisil. The title
compound (0.117 g, 98% yield, > 99% pure on GC analysis) was
obtained as a colorless oil after silica gel column chromatography
(hexane/AcOEt = 50/1). Rf = 0.69 (hexane/AcOEt = 10/1); IR (neat)
2926, 2855, 1461, 1388, 1361, 1256, 1099, 1106, 966, 939, 833, 773,
662; 1H NMR (CDCl3, 392 MHz) δ 0.04 (s, 6H), 0.89 (s, 9H), 1.24−
1.33 (m, 2H), 1.39−1.74 (m, 12H), 2.00 (dt, J = 7.2 and 6.3 Hz, 2H),
2.05−2.12 (m, 1H), 3.60 (t, J = 6.3 Hz, 2H), 5.31 (dt, J = 15.4 and 6.3
Hz, 1H), 5.41 (dd, J = 7.2 and 15.4 Hz, 1H); 13C NMR (CDCl3, 98.5
MHz) δ −5.3 (2C), 18.4, 26.0 (3C), 26.2 (2C), 28.4 (2C), 28.8, 32.8,
35.0 (2C), 42.8, 62.6, 126.3, 137.7; HRMS (EI) m/z [M − t-Bu]+
calcd for C14H27OSi 239.1831; found 239.1828.
50/1). Rf = 0.48 (hexane/AcOEt = 4/1); mixture of cis and trans
isomers: IR (neat) 3025, 2929, 2859, 1730, 1599, 1492, 1448, 1368,
1
1233, 1157, 1123, 1090, 1027, 965, 899, 842, 745, 693; H NMR
(CDCl3, 392 MHz) δ 1.25−1.48 (m, 4H), 1.56−1.69 (m, 2H), 1.89−
1.92 (m, 2H), 2.04 (s, 3H), [2.07 (s, 3H)], 2.13−2.16 (m, 1H), [2.23
(br, 1H)], 4.70 (m, 1H), [5.00 (m, 1H)], 6.13 (dd, J = 6.1 and 15.9
Hz, 1H), [6.21 (dd, J = 6.7 and 15.9 Hz, 1H)], 6.37 (d, J = 15.9 Hz,
1H), [6.39 (d, J = 15.9 Hz, 1H)], 7.17−7.21 (m, 1H), 7.26−7.37 (m,
4H); 13C NMR (CDCl3, 98.5 MHz) δ 21.4, 29.2 (2C) [27.3, 2C], 31.3
(2C) [30.7, 2C], 40.1 [39.5], 72.9 [69.6], 126.0 (2C) [126.0, 2C],
127.0 [126.0], 128.2 [128.0], 128.5 (2C) [128.5, 2C], 134.9 [135.4],
137.6 [137.7], 170.6; HRMS (EI) m/z [M]+ calcd for C16H20O2
244.1463; found 244.1455. The values in parentheses refer to the
minor (cis) isomer.
Synthesis of (Z)-tert-Butyl[(5-cycloheptylpent-4-en-1-yl)oxy]-
dimethylsilane (4b). The reaction was carried out according to
Procedure A on a 0.40 mmol scale by using bromocycloheptane (71.6
mg, 0.40 mmol), 2-[(1Z)-5-tert-butyldimethylsilyloxypent-1-en-1-yl]-
4,4,5,5-tetramethyl-1,3,2-dioxaborolane (0.196 g, 0.60 mmol), t-BuLi
(0.35 mL, 1.59 M in pentane, 0.56 mmol), MgBr2 (0.80 mL, 0.10 M in
THF, 80 μmol), and iron complex 1a (0.40 mL, 50.0 mM in THF, 20
μmol, 5.0 mol %). Conditions: −20 °C, 24 h. The title compound
(0.112 g, 93% yield, > 99% pure on GC analysis) was obtained as a
colorless oil after silica gel column chromatography (hexane/AcOEt =
50/1). Rf = 0.66 (hexane/AcOEt = 10/1); IR (neat) 2926, 2855, 1471,
1461, 1388, 1361, 1254, 1100, 1006, 988, 939, 833, 773, 728, 679, 662;
1H NMR (CDCl3, 392 MHz) δ 0.05 (s, 6H), 0.90 (s, 9H), 1.23−1.32
(m, 2H), 1.42−1.66 (m, 12H), 2.08 (dt, J = 7.2 and 7.6 Hz, 2H),
2.40−2.49 (m, 1H), 3.61 (t, J = 6.3 Hz, 2H), 5.19 (dt, J = 7.2 and 10.5
Hz, 1H), 5.31 (dd, J = 9.9 and 10.5 Hz, 1H); 13C NMR (CDCl3, 98.5
MHz) δ −5.3 (2C), 18.3, 23.6, 26.0 (3C), 26.4 (2C), 28.4 (2C), 33.1,
35.3 (2C), 37.8, 62.7, 125.9, 137.4; HRMS (EI) m/z [M − t-Bu]+
calcd for C14H27OSi 239.1831.; found 239.1832.
Synthesis of (E)-(2-Cycloheptylethenyl)benzene (4c). The reaction
was carried out according to Procedure A on a 0.51 mmol scale by
using bromocycloheptane (89.5 mg, 0.51 mmol), (E)-4,4,5,5-
tetramethyl-2-(2-phenylethenyl)-1,3,2-dioxaborolane (0.173 g, 0.75
mmol), t-BuLi (0.42 mL, 1.65 M in pentane, 0.70 mmol), MgBr2
(1.00 mL, 0.10 M in THF, 0.10 mmol), and iron complex 1a (0.50
mL, 50.0 mM in THF, 25 μmol, 5.0 mol %). Conditions: −20 °C, 24
h. The title compound (96.8 mg, 96% yield, 99% pure on GC analysis)
was obtained as a colorless oil after silica gel column chromatography
(100% hexane). 1H and 13C NMR spectra have been attached.
Analytical data for the title compound have been reported.11
Synthesis of (E)-Oct-4-en-4-ylcycloheptane (4d). The reaction was
carried out according to Procedure A on a 0.40 mmol scale by using
bromocycloheptane (71.1 mg, 0.40 mmol), (Z)-4,4,5,5-tetramethyl-2-
(oct-4-en-4-yl)-1,3,2-dioxaborolane (0.191 g, 0.80 mmol), BuLi (0.48
mL, 1.59 M in hexane, 0.76 mmol), MgBr2 (0.80 mL, 0.10 M in THF,
80.0 μmol), and iron complex 1a (0.400 mL, 50.0 mM in THF, 20
μmol, 5.0 mol %). Conditions: 40 °C, 24 h. The title compound (48.6
mg, 58% yield, > 99% pure on GC analysis) was obtained as a colorless
oil after silica gel column chromatography (100% hexane). Rf = 0.68
(100% hexane); IR (neat) 2956, 2922, 2858, 1458, 1376, 1260, 1068,
892, 805, 741; 1H NMR (CDCl3, 392 MHz) δ 0.88 (t, J = 7.2 Hz, 3H),
0.90 (t, J = 7.2 Hz, 3H), 1.25−1.40 (m, 8H), 1.48−1.62 (m, 4H),
1.67−1.71 (m, 4H), 1.92−1.97 (m, 5H), 5.08 (t, J = 7.2 Hz, 1H); 13C
NMR (CDCl3, 98.5 MHz) δ 13.9, 14.5, 22.7, 23.4, 27.2 (2C), 27.9
(2C), 29.8, 32.6, 35.1 (2C), 47.3, 122.5, 146.6; HRMS (EI) m/z [M]+
calcd for C15H28 208.2191; found 208.2185.
Synthesis of (E)-6-Methyl-1,8-diphenyloct-7-en-1-one (4f). The
reaction was carried out according to Procedure A on a 0.40 mmol
scale by using 6-bromo-1-phenylheptan-1-one (0.107 g, 0.40 mmol),
(E)-4,4,5,5-tetramethyl-2-(2-phenylethenyl)-1,3,2-dioxaborolane
(0.276 g, 1.2 mmol), t-BuLi (0.73 mL, 1.59 M in pentane, 1.16 mmol),
MgBr2 (0.80 mL, 0.10 M in THF, 80.0 μmol), and iron complex 1a
(1.60 mL, 50.0 mM in THF, 80 μmol, 20.0 mol %). Conditions: −20
°C, 24 h. The title compound (97.3 mg, 83% yield, > 98% pure on GC
analysis) was obtained as a colorless oil after purification by GPC
(eluent: CHCl3). Rf = 0.47 (hexane/AcOEt = 4/1); IR (neat) 3059,
3024, 2929, 2865, 1739, 1683, 1597, 1579, 1492, 1448, 1409, 1365,
1279, 1217, 1179, 1072, 1001, 966, 912, 848, 746, 690, 657; 1H NMR
(CDCl3, 392 MHz) δ 1.08 (d, J = 6.7 Hz, 3H), 1.38−1.46 (m, 4H),
1.70−1.79 (m, 2H), 2.31 (m, 1H), 2.96 (t, J = 7.2 Hz, 2H), 6.08 (dd, J
= 8.0 and 15.7 Hz, 1H), 6.34 (d, J = 15.7 Hz, 1H), 7.17−7.21 (m, 1H),
7.26−7.36 (m, 4H), 7.43−7.47 (m, 2H), 7.52−7.57 (m, 1H), 7.93−
7.96 (m, 2H); 13C NMR (CDCl3, 98.5 MHz) δ 20.7, 24.4, 27.2, 36.9,
37.2, 38.6, 126.0 (2C), 126.8, 128.0 (2C), 128.2, 128.4 (2C), 128.5
(2C), 132.9, 136.7, 137.0, 137.8, 200.5; HRMS (EI) m/z [M]+ calcd
for C21H24O 292.1827; found 292.1828.
Synthesis of 1-Benzyloxycarbonyl-4-[(1E)-2-cyclopropylvinyl]-
piperidine (4g). The reaction was carried out according to Procedure
A on a 0.42 mmol scale by using 4-bromo-N-(benzyloxycarbonyl)-
piperidine (0.125 g, 0.42 mmol), (E)-2-(2-cyclopropylethenyl)-4,4,5,5-
tetramethyl-1,3,2-dioxaborolane (0.116 g, 0.60 mmol), t-BuLi (0.35
mL, 1.59 M in pentane, 0.56 mmol), MgBr2 (0.80 mL, 0.10 M in THF,
80 μmol), and iron complex 1a (0.40 mL, 50.0 mM in THF, 20 μmol,
5.0 mol %). Conditions: 0 °C, 24 h. The title compound (0.102 g, 85%
yield, > 99% pure on GC analysis) was obtained as a white solid after
silica gel column chromatography (hexane/AcOEt = 50/1 to 20/1). Rf
= 0.42 (hexane/AcOEt = 4/1); IR (neat) 3006, 2932, 2852, 1694,
1498, 1468, 1427, 1363, 1289, 1275, 1246, 1217, 1171, 1118, 1071,
1016, 962, 910, 865, 811, 763, 731, 696; 1H NMR (CDCl3, 392 MHz)
δ 0.29−0.33 (m, 2H), 0.64−0.69 (m, 2H), 1.21−1.34 (m, 3H), 1.64−
1.67 (m, 2H), 2.02−2.11 (m, 1H), 2.77−2.83 (m, 2H), 4.15 (br, 2H),
4.95 (dd, J = 8.5 and 15.2 Hz, 1H), 5.12 (s, 2H), 5.44 (dd, J = 6.7 and
15.2 Hz, 1H), 7.30−7.32 (m, 1H), 7.35−7.36 (m, 4H); 13C NMR
(CDCl3, 98.5 MHz) δ 6.5 (2C), 13.6, 32.0, 38.6 (2C), 44.0 (2C), 66.9,
127.8 (2C), 127.9, 128.4 (2C), 131.8, 132.8, 137.0, 155.3; HRMS (EI)
m/z [M]+ calcd for C18H23NO2 285.1729; found 285.1724.
Synthesis of 1-Benzyloxycarbonyl-4-(1-phenylvinyl)piperidine
(4h). The reaction was carried out according to Procedure A on a
0.40 mmol scale by using 4-bromo-N-(benzyloxycarbonyl)piperidine
(0.120 g, 0.40 mmol), 4,4,5,5-tetramethyl-2-(1-phenylvinyl)-1,3,2-
dioxaborolane (0.184 g, 0.80 mmol), BuLi (0.48 mL, 1.59 M in
hexane, 0.76 mmol), MgBr2 (0.80 mL, 0.10 M in THF, 80 μmol), and
iron complex 1a (0.80 mL, 50.0 mM in THF, 40 μmol, 10.0 mol %).
Conditions: 40 °C, 24 h. The title compound (99.1 mg, 77% yield, >
99% pure on GC analysis) was obtained as a white solid after silica gel
column chromatography (hexane/AcOEt = 50/1 to 20/1). Rf = 0.38
(hexane/AcOEt = 4/1); IR (neat) 3032, 2939, 2855, 1693, 1626,
1495, 1468, 1427, 1381, 1363, 1318, 1275, 1253, 1217, 1125, 1074,
1027, 943, 900, 865, 776, 763, 732, 696; 1H NMR (CDCl3, 392 MHz)
δ 1.34−1.44 (br, 2H), 1.78−1.81 (br, 2H), 2.59 (tt, J = 3.6 and 11.2
Hz, 1H), 2.83 (br, 2H), 4.26 (br, 2H), 5.00 (s, 1H), 5.13 (s, 2H), 5.18
(s, 1H), 7.27−7.36 (m, 10H); 13C NMR (CDCl3, 98.5 MHz) δ 31.4,
Synthesis of (E)-4-(2-Phenylethenyl)cyclohexyl Acetate (4e). The
reaction was carried out according to Procedure A on a 0.40 mmol
scale by using trans-4-bromocyclohexyl acetate (88.6 mg, 0.40 mmol),
(E)-4,4,5,5-tetramethyl-2-(2-phenylethenyl)-1,3,2-dioxaborolane
(0.140 g, 0.61 mmol), t-BuLi (0.34 mL, 1.65 M in pentane, 0.56
mmol), MgBr2 (0.80 mL, 0.10 M in THF, 80.0 μmol), and iron
complex 1a (0.40 mL, 50.0 mM in THF, 20 μmol, 5.0 mol %).
Conditions: −20 °C, 24 h. The title compounds (85.7 mg, 88% yield,
> 99% pure on GC analysis, cis:trans = 43/57) was obtained as a
colorless oil after silica gel column chromatography (hexane/AcOEt =
1171
dx.doi.org/10.1021/jo202151f | J. Org. Chem. 2012, 77, 1168−1173